David Bennett to Clinical Trials as Topic
This is a "connection" page, showing publications David Bennett has written about Clinical Trials as Topic.
Connection Strength
0.235
-
Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease. Neuroepidemiology. 2014; 43(2):131-9.
Score: 0.109
-
Update on mild cognitive impairment. Curr Neurol Neurosci Rep. 2003 Sep; 3(5):379-84.
Score: 0.050
-
Advances in the prevention of Alzheimer's disease and dementia. J Intern Med. 2014 Mar; 275(3):229-50.
Score: 0.026
-
Early risk assessment for Alzheimer's disease. Alzheimers Dement. 2009 Mar; 5(2):182-96.
Score: 0.018
-
Mild cognitive impairment. Lancet. 2006 Apr 15; 367(9518):1262-70.
Score: 0.015
-
Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan; 61(1):59-66.
Score: 0.013
-
Induction of parkinsonism by intraventricular bethanechol in a patient with Alzheimer's disease. Neurology. 1989 Sep; 39(9):1265.
Score: 0.005